Cite
HARVARD Citation
Trillini, M. et al. (2023). Effects of Octreotide–Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease: Pilot, Randomized, Placebo-Controlled, Cross-Over Trial. Clinical journal of the American Society of Nephrology. 18 (2), pp. 223-233. [Online].